1. Home
  2. IMCR vs KLG Comparison

IMCR vs KLG Comparison

Compare IMCR & KLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMCR
  • KLG
  • Stock Information
  • Founded
  • IMCR 2008
  • KLG 2022
  • Country
  • IMCR United Kingdom
  • KLG United States
  • Employees
  • IMCR N/A
  • KLG N/A
  • Industry
  • IMCR Biotechnology: Biological Products (No Diagnostic Substances)
  • KLG Packaged Foods
  • Sector
  • IMCR Health Care
  • KLG Consumer Staples
  • Exchange
  • IMCR Nasdaq
  • KLG Nasdaq
  • Market Cap
  • IMCR 1.5B
  • KLG 1.5B
  • IPO Year
  • IMCR 2021
  • KLG N/A
  • Fundamental
  • Price
  • IMCR $32.77
  • KLG $17.05
  • Analyst Decision
  • IMCR Buy
  • KLG Sell
  • Analyst Count
  • IMCR 10
  • KLG 7
  • Target Price
  • IMCR $58.13
  • KLG $16.86
  • AVG Volume (30 Days)
  • IMCR 445.1K
  • KLG 884.3K
  • Earning Date
  • IMCR 08-07-2025
  • KLG 08-05-2025
  • Dividend Yield
  • IMCR N/A
  • KLG 3.87%
  • EPS Growth
  • IMCR N/A
  • KLG N/A
  • EPS
  • IMCR N/A
  • KLG 0.65
  • Revenue
  • IMCR $333,581,000.00
  • KLG $2,664,000,000.00
  • Revenue This Year
  • IMCR $26.82
  • KLG N/A
  • Revenue Next Year
  • IMCR $8.15
  • KLG N/A
  • P/E Ratio
  • IMCR N/A
  • KLG $26.15
  • Revenue Growth
  • IMCR 25.75
  • KLG N/A
  • 52 Week Low
  • IMCR $23.15
  • KLG $14.80
  • 52 Week High
  • IMCR $41.54
  • KLG $22.21
  • Technical
  • Relative Strength Index (RSI)
  • IMCR 45.73
  • KLG 60.81
  • Support Level
  • IMCR $30.76
  • KLG $15.38
  • Resistance Level
  • IMCR $32.55
  • KLG $16.04
  • Average True Range (ATR)
  • IMCR 1.39
  • KLG 0.55
  • MACD
  • IMCR -0.41
  • KLG 0.18
  • Stochastic Oscillator
  • IMCR 19.09
  • KLG 73.28

About IMCR Immunocore Holdings plc

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

About KLG WK Kellogg Co

WK Kellogg is the second-largest cereal manufacturer in North America. Its cereal brands include Special K, Frosted Flakes, Raisin Bran, Froot Loops, Frosted Mini-Wheats, Kashi, Corn Flakes, Rice Krispies, Apple Jacks, and Bear Naked. The company was spun off from the former Kellogg business, now known as Kellanova, where the former firm's global snacks portfolio and international cereal brands are now housed. WK Kellogg, which began trading independently in October 2023, generates the bulk of its sales (about 88% of its fiscal 2024 base) in the US.

Share on Social Networks: